BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
16.85
-0.14 (-0.82%)
At close: Oct 31, 2025, 4:00 PM EDT
17.00
+0.15 (0.89%)
After-hours: Oct 31, 2025, 7:52 PM EDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $332.16 million as of October 31, 2025. Its market cap has increased by 110.13% in one year.
Market Cap
332.16M
Enterprise Value
257.94M
1-Year Change
110.13%
Ranking
Category
Stock Price
$16.85
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $332.16M, an increase of 85.65%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2025 | 332.16M | 84.16% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 756.15B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.29B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.79B |